Evidence map›Paper›PMID 41628331›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Neuron-specific modulation of SLC30A10 identifies dopaminergic and glutamatergic neurons as targets of manganese-induced motor disease.

Stephanie M Grant, Ashvini Melkote, Mollie X Bernstein, Thomas Jursa, Cherish A Taylor, Steven Hutchens, William Shawlot, Larry S Zweifel, Rueben A Gonzales, Donald R Smith and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stephanie M Grant *Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712.
Ashvini Melkote *Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712.ORCID 0009-0005-8728-8813
Mollie X BernsteinDepartment of Pharmacology, University of Washington, Seattle, WA 98195.ORCID 0000-0003-2327-5771
Thomas JursaDepartment of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA 95064.ORCID 0000-0002-7264-904X
Cherish A TaylorDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712.
Steven HutchensDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712.
William ShawlotMouse Genetic Engineering Facility, Center for Biomedical Research Support, University of Texas at Austin, Austin, TX 78712.ORCID 0009-0008-3539-7366
Larry S ZweifelDepartment of Pharmacology, University of Washington, Seattle, WA 98195.ORCID 0000-0003-3465-5331
Rueben A GonzalesDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712.
Donald R SmithDepartment of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA 95064.
Somshuvra MukhopadhyayDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712.ORCID 0000-0002-3420-7830

Funding

Regulation of manganese homeostasis and detoxification by SLC30A10R01ES024812 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI Somshuvra Mukhopadhyay · 2016 to 2026
$5.7M
Role and mechanisms of excretion in manganese neurotoxicityR01ES031574 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI MUKHOPADHYAY, SOMSHUVRA · 2020 to 2025
$3.5M
Identifying neuronal targets and mechanisms of manganese-induced neuromotor diseaseF31ES036908 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI MELKOTE, ASHVINI · 2024 to 2025
$82k
HHS | NIH | National Institute of Environmental Health Sciences (DEHS) F31-ES036908NIEHS NIH HHS F31 ES036908NIEHS NIH HHS R01 ES024812NIEHS NIH HHS R01 ES031574
6 · The paper itself

Abstract

Essential metals accumulate in the basal ganglia at elevated levels and induce incurable motor disease. But, unlike other motor diseases, the neuronal targets of essential metals are unknown, and this fundamental knowledge gap has limited therapeutic progress. Because metal efflux transporters have high specificity, we hypothesized that neuron-specific knockout or knockin (i.e., overexpression) of efflux transporters may alter metal levels in targeted neurons and define the neuronal targets of metal-induced disease. To test this, we focused on manganese (Mn)-induced motor disease, which is a public health problem. We generated six neuron-specific

Indexed as

Cation Transport ProteinsDopaminergic NeuronsManganeseMotor DisordersNeuronsAnimalsGlutamic AcidMiceMice, KnockoutCation Transport ProteinsGlutamic AcidManganesebasal gangliamanganesemetal homeostasismetal transporterparkinsonism

Identifiers

PMID41628331
PMCPMC12890882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.